We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Dotmatics Informatics Selected to Enhance Research at Moulder Center for Drug Discovery
News

Dotmatics Informatics Selected to Enhance Research at Moulder Center for Drug Discovery

Dotmatics Informatics Selected to Enhance Research at Moulder Center for Drug Discovery
News

Dotmatics Informatics Selected to Enhance Research at Moulder Center for Drug Discovery

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Dotmatics Informatics Selected to Enhance Research at Moulder Center for Drug Discovery"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

"After a thorough review of the commercially available software packages for sharing and exploiting the fruits of drug discovery research, it became clear that the Dotmatics platform represented not only the best configuration, but also the most comprehensive package available" said Dr. Magid Abou-Gharbia, Associate Dean for Research and Director of the Moulder Center. "In building our capacity at the Moulder Center for Drug Discovery Research we are focused on efficiently generating research data using a host of technologies and tools. The combination of Browser, Vortex and StudiesNotebook are key solutions which will allow our scientists to quickly triage, integrate and analyze data from multiple sources, speeding the pace and efficiency of research. These advantages afford our scientists increased opportunity to improve the health of patients through the discovery of new therapeutic agents."

The migration of The Moulder Center for Drug Discovery Research's legacy database to the Dotmatics platform will have a positive and dramatic impact on research workflow. Dr. Abou-Gharbia continued “Researchers at our center will benefit from the advanced data querying, analysis and reporting tools provided by this high end informatics platform. In addition, the secure web-based deployment of Dotmatics software will allow our external collaborators to easily access their data while maintaining safeguards against the release of data from unrelated programs. Our adoption of the Dotmatics system provides The Moulder Center with cutting edge Cheminformatics and database capabilities.”

Advertisement